ÂÜÀòÂÒÂ×

Amir Naiberg serves as the Associate Vice Chancellor of the UCLA Technology Development Group, contributing to the advancement of technology in academic settings. In addition to this role, Amir Naiberg holds various board observer positions at TORL BioTherapeutics, LLC, 1200 Pharma, and MBcure Ltd., showcasing a commitment to innovation in the biotech sector. Amir Naiberg is also an active board member of the Alliance for Southern California Innovation, further promoting collaboration in the region. Educationally, Amir Naiberg is pursuing studies at the University of Connecticut School of Law and The Hebrew University of Jerusalem, enhancing a strong foundation in legal and academic affairs.